Pomegra
Wendy's Stock Rises 1% After Rejecting Takeover Bid
Why is Wendy's stock up today?
Wendy's (WEN) stock rose about 1% to $7.75 on Thursday after its board rejected a $1.4B, $7.35-a-share takeover offer from a Trian-led group and adopted a poison pill.
Key numbers
| Offer per share (cash) | $7.35about 20% premium when made |
|---|---|
| Total offer value | $1.4Brejected Nov 5 |
| WEN share price | $7.75+about 1% on Thursday |
| Investor group stake | 16.3%poison pill triggers at 15% |
| Q3 revenue | $547Mvs $531M expected (per [4]) |
What happened
Wendy's (WEN) stock rose about 1% to $7.75 on Thursday after its board rejected a $1.4B, $7.35-a-share takeover offer from a Trian-led group and adopted a poison pill. A poison pill is a defense that makes it costly for any investor to build a stake of 15% or more without board approval. Trian Fund Management, run by Nelson Peltz, and its partners already own 16.3% of Wendy's. The board said the offer, made October 28 at roughly a 20% premium at the time, "substantially undervalues" the company, and the group refused to sign an agreement limiting its stake (a standstill).
Why it matters
Wendy's (WEN) is a struggling burger chain whose shares have lost about 60% of their value over three years. Saying no means shareholders will not get the $7.35 in cash for now, even though the stock is trading above that price. Sales at existing restaurants have fallen for seven straight quarters, so the board is relying on a turnaround plan under new CEO Bob Wright to be worth more than the bid.
Who this affects
- MarketmixedLow impact
- Shareholders forgo $7.35 cash for now; stock holds above it.
- CompanymixedMedium impact
- Wendy's keeps control for now but faces a 16.3% holder.
- CompetitorsneutralLow impact
- Rivals such as McDonald's see little direct effect.
- IndustryneutralLow impact
- Shows buyout interest in struggling fast-food chains.
Wendy's vs McDonald's, Restaurant Brands, Jack in the Box
How we got here
Trian-led group sends Wendy's an unsolicited $7.35-a-share cash proposal
Wendy's board adopts a one-year shareholder rights plan (poison pill)
Independent committee unanimously rejects the offer; Wendy's also reports third-quarter results
What to watch
- Whether the Trian-led group raises its bid or responds to the rejectionQ4 2026
- Record date for shareholders under the new rights plan2026-11-16
- Rights plan expires unless extended or ended earlier by the board2027-11-03
Educational content only. Not investment advice.
More briefsAll briefs →
HubSpot Stock Falls 4.8% After Weak Q4 Guidance
HubSpot (HUBS) trades near $206 after Cantor Fitzgerald cut it to Underweight with a $170 target.
Zillow Stock Falls 9% After Q3 Earnings Miss
Zillow (Z) revenue of $724M missed forecasts and its next-quarter outlook disappointed as mortgage rates bite
Unity Stock Jumps 22% Premarket After Earnings Beat
Unity (U) posted $622M in Q3 sales, up 32%, plus its first GAAP profit, as AI ad tool Vector grew 126%.